AMPH vs REG · P/E 12, rev $732.0M vs P/E 34, $12.93B cap
Amphastar P (AMPH) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
REG does not have a complete income-statement cache yet.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the AMPH and REG stock pages for the full models.
Not investment advice.